Filing Details

Accession Number:
0001209191-23-001902
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-05 16:46:16
Reporting Period:
2023-01-03
Accepted Time:
2023-01-05 16:46:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1786205 Arcellx Inc. ACLX Biological Products, (No Disgnostic Substances) (2836) 472855917
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789632 Christopher Heery C/O Arcellx, Inc.
25 West Watkins Mill Road, Suite A
Gaithersburg MD 20878
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-03 2,500 $15.00 2,500 No 4 M Direct
Common Stock Disposition 2023-01-03 2,500 $31.11 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2023-01-03 76,242 $0.00 76,242 $31.03
Common Stock Restricted Stock Unit Acquisiton 2023-01-03 49,558 $0.00 49,558 $0.00
Common Stock Stock Option (right to buy) Disposition 2023-01-03 2,500 $0.00 2,500 $15.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
76,242 2033-01-03 No 4 A Direct
49,558 No 4 A Direct
250,205 2032-02-03 No 4 M Direct
Footnotes
  1. The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 30, 2022.
  2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option will vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (or, if there is no corresponding day in a particular month, then the last day of the month) over four (4) years. "Vesting Commencement Date" shall mean January 1, 2023.
  3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the RSUs subject to the award will vest each year following the RSU Grant Date on the same day of the month as the RSU Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. "RSU Grant Date" shall mean January 3, 2023.
  5. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option will vest each month following Equity Grant Date on the same day of the month as the Equity Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over four (4) years. "Equity Grant Date" shall mean February 3, 2022.